Skip to main content
NIH funding notice PAR-14-104

Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R03)

Closed on January 7, 2018.

Posted
February 25, 2014
Close date
January 7, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $151,750 in first-year total cost, median $75,875.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 IFCN-C (56)]1
  2. Special Emphasis Panel[ZRG1 IFCN-L (56)]1

Most frequent institutions

  1. UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS1
  2. WEST VIRGINIA UNIVERSITY1
Competing awards under PAR-14-104 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018High throughput approaches to determining the lethality of synthetic psychoactive cathinones using Danio rerio larvae1R03DA045350-01A1HALL, FRANK SCOTTUNIVERSITY OF TOLEDO HEALTH SCI CAMPUS, OH$76,750ZRG1
2018Reducing the deleterious effects of synthetic cannabinoid withdrawal on emotionality and motivation1R03DA039335-01A1KINSEY, STEVEN G.WEST VIRGINIA UNIVERSITY, WV$75,000ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.